Flagship research program
A guided computational program for moving from declared cancer molecular data to evidence-supported biological hypotheses, with validation state kept visible.
Cancer Discovery Pipeline
The user-facing workflow stays continuous while project manifests preserve the engineering boundaries, dependency graph, and typed artifact contracts underneath.
Declare versioned research inputs and provenance.
Characterize molecular context without claiming a diagnosis.
Register candidate feature evidence for evaluation.
Evaluate candidate dependencies and selectivity.
Connect candidate hypotheses to registered response evidence.
Expose independent, robustness, and replication checks.
Package provenance and approved research artifacts.
Registered modules
These records come from the generated catalog. A registered scaffold does not imply a completed run, a validated output, or clinical readiness.
Research-only molecular-state modeling project with independently versioned task contracts. T001 includes metadata and read-only compatibility validation for the completed legacy TCGA-BRCA TP53 candidate. The current platform specification remains unapproved and cannot pass G0 or produce a release.
Contract scaffold for integrating molecular-state evidence with functional, pharmacological, and proteomic evidence to evaluate candidate vulnerabilities. No vulnerability analysis or validation is implemented.
Current research state
Only immutable, validated records should be shown as scientific outputs.
Registration metadata only; source data are not bundled into the site.
Release records remain separate from project scaffolds and schema declarations.
Not for diagnosis, treatment selection, or patient-level inference.
Registry ready
Results and evidence panels remain empty until a project produces an immutable release that satisfies the platform validation lifecycle.
Review the validation approach